The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients

• Background: Peritonitis is the most important complication of peritoneal dialysis. The most common cause of peritonitis is catheter exit site infection. Several studies have shown the prophylactic effect of topical mupirocin. According to the report of drug resistance in several studies to muproci...

Full description

Bibliographic Details
Main Authors: Mojgan Mortazavi, Mehran Halabian, Shiva Seirafian, Afsoon Emami, Ziba Farajzadegan, Firoozeh Moinzadeh, Shirin Karimi
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2011-03-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/719
_version_ 1827845545932095488
author Mojgan Mortazavi
Mehran Halabian
Shiva Seirafian
Afsoon Emami
Ziba Farajzadegan
Firoozeh Moinzadeh
Shirin Karimi
author_facet Mojgan Mortazavi
Mehran Halabian
Shiva Seirafian
Afsoon Emami
Ziba Farajzadegan
Firoozeh Moinzadeh
Shirin Karimi
author_sort Mojgan Mortazavi
collection DOAJ
description • Background: Peritonitis is the most important complication of peritoneal dialysis. The most common cause of peritonitis is catheter exit site infection. Several studies have shown the prophylactic effect of topical mupirocin. According to the report of drug resistance in several studies to muprocin and exit site infection with gram-negative organisms, this study compared the prophylacyic effect of gentamicin with muprocin. • Methods: This double blind clinical trial was done on 121 peritoneal dialysis patients. We have investigated the frequency of peritonitis and exit site infection in 2 groups receiving gentamicin and mupirocin ointment for 6 months. Data were analyzed by SPSS software using Student-t, chi-square and logistic regression tests. • Finding: After six months, 8 cases of peritonitis were reported in gentamicin group compared to no cases in mupirocin group (P = 0.03). The exit site infection in the fourth and fifth months in the gentamicin group compared to mupirocin group was respectively 4.2 and 3.3 times (P = 0.0001). • Conclusion: According to the results of this study, gentamicin ointment have not shown a prophylactic effect on the incidence of exit site infection and peritonitis compared with mupirocin ointment and it is not recommended as a substitute.
first_indexed 2024-03-12T08:59:53Z
format Article
id doaj.art-97025f93d2794cfa9b55820b1ccf9da7
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T08:59:53Z
publishDate 2011-03-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-97025f93d2794cfa9b55820b1ccf9da72023-09-02T15:45:44ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2011-03-012811610621069502The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis PatientsMojgan Mortazavi0Mehran Halabian1Shiva Seirafian2Afsoon Emami3Ziba Farajzadegan4Firoozeh Moinzadeh5Shirin Karimi6Isfahan Kidney Diseases Research Center, Assistant Professor, Department of Nephrology, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.Nephrology Resident, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Isfahan Kidney Diseases Research Center, Associate Professor, Department of Nephrology, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.Isfahan Kidney Diseases Research Center, Associate Professor, Department of Nephrology, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.Associate Professor, Department of Social Medicine, School of Medicine ,Isfahan University of Medical Sciences, Isfahan, Iran.Internal Medicine Resident, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Nurse, Peritoneal Dialysis, Alzahra Hospital, Isfahan, Iran.• Background: Peritonitis is the most important complication of peritoneal dialysis. The most common cause of peritonitis is catheter exit site infection. Several studies have shown the prophylactic effect of topical mupirocin. According to the report of drug resistance in several studies to muprocin and exit site infection with gram-negative organisms, this study compared the prophylacyic effect of gentamicin with muprocin. • Methods: This double blind clinical trial was done on 121 peritoneal dialysis patients. We have investigated the frequency of peritonitis and exit site infection in 2 groups receiving gentamicin and mupirocin ointment for 6 months. Data were analyzed by SPSS software using Student-t, chi-square and logistic regression tests. • Finding: After six months, 8 cases of peritonitis were reported in gentamicin group compared to no cases in mupirocin group (P = 0.03). The exit site infection in the fourth and fifth months in the gentamicin group compared to mupirocin group was respectively 4.2 and 3.3 times (P = 0.0001). • Conclusion: According to the results of this study, gentamicin ointment have not shown a prophylactic effect on the incidence of exit site infection and peritonitis compared with mupirocin ointment and it is not recommended as a substitute.http://jims.mui.ac.ir/index.php/jims/article/view/719Peritoneal dialysisPeritonitisExit site infectionGentamicin ointmentMupirocin ointment
spellingShingle Mojgan Mortazavi
Mehran Halabian
Shiva Seirafian
Afsoon Emami
Ziba Farajzadegan
Firoozeh Moinzadeh
Shirin Karimi
The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
مجله دانشکده پزشکی اصفهان
Peritoneal dialysis
Peritonitis
Exit site infection
Gentamicin ointment
Mupirocin ointment
title The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
title_full The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
title_fullStr The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
title_full_unstemmed The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
title_short The Effect of Topical Gentamicin and Mupirocin on Peritonitis and Exit Site Infection in Peritoneal Dialysis Patients
title_sort effect of topical gentamicin and mupirocin on peritonitis and exit site infection in peritoneal dialysis patients
topic Peritoneal dialysis
Peritonitis
Exit site infection
Gentamicin ointment
Mupirocin ointment
url http://jims.mui.ac.ir/index.php/jims/article/view/719
work_keys_str_mv AT mojganmortazavi theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT mehranhalabian theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT shivaseirafian theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT afsoonemami theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT zibafarajzadegan theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT firoozehmoinzadeh theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT shirinkarimi theeffectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT mojganmortazavi effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT mehranhalabian effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT shivaseirafian effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT afsoonemami effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT zibafarajzadegan effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT firoozehmoinzadeh effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients
AT shirinkarimi effectoftopicalgentamicinandmupirocinonperitonitisandexitsiteinfectioninperitonealdialysispatients